CryoPort(DE:CKX)
€18.50+0.50 (+2.78%)
DE:CKX
CryoPort financials statements
€18.50
At close:+0.50 (+2.78%)
CryoPort (CKX) Ratios
0 Followers
CryoPort Ratios
DE:CKX's free cash flow for Q3 2026 was $-40.00K. For the 2026 fiscal year, DE:CKX's free cash flow was decreased by $-5.25M and operating cash flow was $5.21M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.17 | 5.29 | 11.73 | 14.79 | 4.20 |
| Quick Ratio | 2.07 | 4.94 | 11.16 | 14.11 | 3.90 |
| Cash Ratio | 1.14 | 0.70 | 1.02 | 0.90 | 1.05 |
| Solvency Ratio | 0.40 | -0.24 | -0.03 | -0.53 | -0.13 |
| Operating Cash Flow Ratio | -0.04 | -0.25 | -0.02 | -0.05 | -0.42 |
| Short-Term Operating Cash Flow Coverage | -0.05 | -1.13 | -5.08 | -30.85 | 0.00 |
| Net Current Asset Value | $ 213.82M | $ 39.98M | $ 66.39M | $ 121.27M | $ -22.55M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.30 | 0.36 | 0.43 | 0.42 | 0.24 |
| Debt-to-Equity Ratio | 0.46 | 0.62 | 0.85 | 0.78 | 0.34 |
| Debt-to-Capital Ratio | 0.31 | 0.38 | 0.46 | 0.44 | 0.25 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.32 | 0.44 | 0.42 | 0.23 |
| Financial Leverage Ratio | 1.52 | 1.75 | 1.96 | 1.87 | 1.44 |
| Debt Service Coverage Ratio | -0.02 | -3.34 | -1.34 | -52.77 | -7.92 |
| Interest Coverage Ratio | -15.59 | -20.93 | -5.19 | -3.80 | -11.72 |
| Debt to Market Cap | 0.39 | 0.53 | 0.50 | 0.51 | 0.07 |
| Interest Debt Per Share | 4.65 | 5.26 | 8.62 | 9.59 | 3.46 |
| Net Debt to EBITDA | 9.43 | -3.10 | -59.75 | -1.60 | -4.63 |
| Profitability Margins | |||||
| Gross Profit Margin | 47.14% | 42.59% | 43.78% | 43.38% | 46.17% |
| EBIT Margin | -16.92% | -40.23% | -12.20% | -120.91% | -38.35% |
| EBITDA Margin | -1.19% | -28.45% | -2.61% | -111.81% | -25.81% |
| Operating Profit Margin | -20.89% | -49.37% | -13.45% | -8.01% | -38.13% |
| Pretax Profit Margin | -18.26% | -42.59% | -14.79% | -123.02% | -41.60% |
| Net Profit Margin | 44.44% | -42.69% | -15.73% | -123.77% | -41.54% |
| Continuous Operations Profit Margin | -19.28% | -42.69% | -15.73% | -123.77% | -41.54% |
| Net Income Per EBT | -243.40% | 100.24% | 106.38% | 100.62% | 99.86% |
| EBT Per EBIT | 87.40% | 86.27% | 110.00% | 1535.94% | 109.09% |
| Return on Assets (ROA) | 10.24% | -14.16% | -3.90% | -26.53% | -5.92% |
| Return on Equity (ROE) | 15.58% | -24.78% | -7.63% | -49.57% | -8.54% |
| Return on Capital Employed (ROCE) | -6.74% | -18.02% | -3.50% | -1.79% | -5.80% |
| Return on Invested Capital (ROIC) | -5.00% | -17.47% | -3.48% | -1.78% | -5.77% |
| Return on Tangible Assets | 12.95% | -20.69% | -5.70% | -39.55% | -16.92% |
| Earnings Yield | 16.29% | -26.26% | -4.92% | -34.58% | -1.93% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.28 | 5.10 | 5.64 | 5.08 | 2.51 |
| Payables Turnover | 6.09 | 5.12 | 5.12 | 4.66 | 1.71 |
| Inventory Turnover | 4.02 | 5.96 | 5.09 | 4.55 | 4.02 |
| Fixed Asset Turnover | 1.41 | 1.71 | 2.02 | 2.46 | 1.79 |
| Asset Turnover | 0.23 | 0.33 | 0.25 | 0.21 | 0.14 |
| Working Capital Turnover Ratio | 0.66 | 0.61 | 0.45 | 0.37 | 0.75 |
| Cash Conversion Cycle | 100.10 | 61.56 | 65.14 | 73.74 | 22.24 |
| Days of Sales Outstanding | 69.11 | 71.63 | 64.72 | 71.91 | 145.53 |
| Days of Inventory Outstanding | 90.89 | 61.24 | 71.70 | 80.16 | 90.77 |
| Days of Payables Outstanding | 59.90 | 71.32 | 71.29 | 78.33 | 214.06 |
| Operating Cycle | 160.00 | 132.87 | 136.42 | 152.07 | 236.30 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.17 | -0.33 | -0.02 | -0.04 | -0.39 |
| Free Cash Flow Per Share | -0.56 | -0.69 | -0.93 | -0.57 | -0.64 |
| Dividend Paid and CapEx Coverage Ratio | -0.44 | -0.95 | -0.02 | -0.08 | -1.54 |
| Capital Expenditure Coverage Ratio | -0.44 | -0.95 | -0.02 | -0.08 | -1.54 |
| Operating Cash Flow Coverage Ratio | -0.04 | -0.07 | -0.00 | -0.00 | -0.11 |
| Operating Cash Flow to Sales Ratio | -0.05 | -0.07 | -0.00 | -0.01 | -0.19 |
| Free Cash Flow Yield | -5.84% | -8.86% | -6.02% | -3.27% | -1.45% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 6.86 | -3.81 | -20.33 | -2.89 | -51.78 |
| Price-to-Sales (P/S) Ratio | 2.73 | 1.63 | 3.20 | 3.58 | 21.51 |
| Price-to-Book (P/B) Ratio | 0.96 | 0.94 | 1.55 | 1.43 | 4.42 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -17.12 | -11.29 | -16.62 | -30.59 | -69.00 |
| Price-to-Operating Cash Flow Ratio | -56.02 | -23.23 | -1002.40 | -430.49 | -113.88 |
| Price-to-Earnings Growth (PEG) Ratio | -0.04 | -0.03 | 0.24 | 0.00 | -0.20 |
| Enterprise Value Multiple | -219.80 | -8.81 | -182.39 | -4.81 | -87.99 |
| Enterprise Value | 460.91M | 584.59M | 1.13B | 1.20B | 1.79B |
| EV to EBITDA | -219.80 | -8.81 | -182.39 | -4.81 | -87.99 |
| EV to Sales | 2.62 | 2.51 | 4.76 | 5.37 | 22.71 |
| EV to Free Cash Flow | -16.41 | -17.41 | -24.72 | -45.92 | -72.84 |
| EV to Operating Cash Flow | -53.72 | -35.81 | -1490.71 | -646.22 | -120.21 |
| Tangible Book Value Per Share | 6.83 | 3.69 | 3.80 | 4.65 | 0.61 |
| Shareholders’ Equity Per Share | 10.04 | 8.25 | 9.98 | 12.10 | 9.92 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.06 | -0.00 | -0.06 | -0.01 | 0.00 |
| Revenue Per Share | 3.52 | 4.79 | 4.84 | 4.85 | 2.04 |
| Net Income Per Share | 1.56 | -2.04 | -0.76 | -6.00 | -0.85 |
| Tax Burden | -2.43 | 1.00 | 1.06 | 1.01 | 1.00 |
| Interest Burden | 1.08 | 1.06 | 1.21 | 1.02 | 1.08 |
| Research & Development to Revenue | 0.10 | 0.08 | 0.07 | 0.08 | 0.12 |
| SG&A to Revenue | 0.58 | 0.63 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.06 | 0.08 | 0.10 | 0.09 | 0.11 |
| Income Quality | -0.11 | 0.14 | 0.01 | 0.05 | 0.45 |
Currency in USD
